Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
2018 ◽
Vol 179
(4)
◽
pp. 853-862
◽
F. Valenzuela
◽
N.J. Korman
◽
R. Bissonnette
◽
N. Bakos
◽
T.-F. Tsai
◽
...
Kim A. Papp
◽
Saskia de Vente
◽
Jiewei Zeng
◽
Mary Flack
◽
Byron Padilla
◽
...
2014 ◽
Vol 53
(suppl_1)
◽
pp. i96-i96
◽
Edward Keystone
◽
Robert Landewé
◽
Ronald van Vollenhoven
◽
Bernard Combe
◽
Vibeke Strand
◽
...
2019 ◽
Vol 156
(3)
◽
pp. S25-S26
Walter Reinisch
◽
William J. Sandborn
◽
Silvio Danese
◽
Xavier Hébuterne
◽
Bruce Salzberg
◽
...
Mark A Chilvers
◽
Jane C Davies
◽
Carlos Milla
◽
Simon Tian
◽
Zifei Han
◽
...
Scott MacDiarmid
◽
J.P. Nicandro
◽
Maria Cheng
◽
Steven Abrams
◽
Seymour Fein
◽
...
2002 ◽
Vol 41
(1)
◽
pp. 54-61
◽
P van Kerrebroeck
◽
A Jardin
◽
P van Cangh
◽
K.U Laval
Michael E Wechsler
◽
Linda B Ford
◽
Jorge F Maspero
◽
Ian D Pavord
◽
Alberto Papi
◽
...
2020 ◽
Vol 47
(6)
◽
pp. 569-577
◽
Yukie Yamaguchi
◽
Nobumichi Takatsu
◽
Kenji Ootaki
◽
Hidemi Nakagawa
2016 ◽
Vol 74
(5)
◽
pp. AB251
2011 ◽
Vol 64
(2)
◽
pp. AB148
◽